Exact Mass: 1100.4208

Exact Mass Matches: 1100.4208

Found 9 metabolites which its exact mass value is equals to given mass value 1100.4208, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Levomycin

Quinomycin a

C51H64N12O12S2 (1100.4208)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents

   

Echinomycin

N-(6,19-Dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-2,4,12,15,17,25-hexamethyl-29-(methylsulphanyl)-3,10,13,16,23,26-hexaoxo-11,24-bis(propan-2-yl)-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl)quinoxaline-2-carboximidic acid

C51H64N12O12S2 (1100.4208)


   

Echinomycin

S-426-S (Lepetit)

C51H64N12O12S2 (1100.4208)


D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000970 - Antineoplastic Agents C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

n-[(1s,4r,7s,11r,14s,17r,20s,24r,27s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

n-[(1s,4r,7s,11r,14s,17r,20s,24r,27s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

C51H64N12O12S2 (1100.4208)


   

n-[(7r,11s,24s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

n-[(7r,11s,24s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

C51H64N12O12S2 (1100.4208)


   

2-[1-(15-hydroxy-16-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-6-{2-[(1-hydroxy-2-{[hydroxy(quinoxalin-2-yl)methylidene]amino}prop-2-en-1-ylidene)amino]-n-methylpropanamido}-3-isopropyl-4,11,13-trimethyl-9-(methylsulfanyl)-2,5,12-trioxo-1-oxa-8-thia-4,11,14-triazacycloheptadec-14-en-10-yl)-n-methylformamido]-3-methylbutanoic acid

2-[1-(15-hydroxy-16-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-6-{2-[(1-hydroxy-2-{[hydroxy(quinoxalin-2-yl)methylidene]amino}prop-2-en-1-ylidene)amino]-n-methylpropanamido}-3-isopropyl-4,11,13-trimethyl-9-(methylsulfanyl)-2,5,12-trioxo-1-oxa-8-thia-4,11,14-triazacycloheptadec-14-en-10-yl)-n-methylformamido]-3-methylbutanoic acid

C51H64N12O12S2 (1100.4208)


   

n-(6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl)quinoxaline-2-carboximidic acid

n-(6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl)quinoxaline-2-carboximidic acid

C51H64N12O12S2 (1100.4208)


   

(2s)-2-{1-[(3s,6r,10r,13s,16r)-15-hydroxy-16-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-6-[(2s)-2-[(1-hydroxy-2-{[hydroxy(quinoxalin-2-yl)methylidene]amino}prop-2-en-1-ylidene)amino]-n-methylpropanamido]-3-isopropyl-4,11,13-trimethyl-9-(methylsulfanyl)-2,5,12-trioxo-1-oxa-8-thia-4,11,14-triazacycloheptadec-14-en-10-yl]-n-methylformamido}-3-methylbutanoic acid

(2s)-2-{1-[(3s,6r,10r,13s,16r)-15-hydroxy-16-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-6-[(2s)-2-[(1-hydroxy-2-{[hydroxy(quinoxalin-2-yl)methylidene]amino}prop-2-en-1-ylidene)amino]-n-methylpropanamido]-3-isopropyl-4,11,13-trimethyl-9-(methylsulfanyl)-2,5,12-trioxo-1-oxa-8-thia-4,11,14-triazacycloheptadec-14-en-10-yl]-n-methylformamido}-3-methylbutanoic acid

C51H64N12O12S2 (1100.4208)


   

n-[(1r,4r,7r,11s,14r,17r,20r,24s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

n-[(1r,4r,7r,11s,14r,17r,20r,24s)-6,19-dihydroxy-20-{[hydroxy(quinoxalin-2-yl)methylidene]amino}-11,24-diisopropyl-2,4,12,15,17,25-hexamethyl-27-(methylsulfanyl)-3,10,13,16,23,26-hexaoxo-9,22-dioxa-28-thia-2,5,12,15,18,25-hexaazabicyclo[12.12.3]nonacosa-5,18-dien-7-yl]quinoxaline-2-carboximidic acid

C51H64N12O12S2 (1100.4208)